{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:08:06Z","timestamp":1773198486976,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    Type I Bartter syndrome is a rare autosomal recessive tubulopathy resulting from mutations in the SLC12A1 gene, leading to defective sodium\u2013chloride reabsorption in the thick ascending limb of the loop of Henle. Affected neonates typically present with profound fluid and electrolyte disturbances, polyuria, and metabolic derangements. Early diagnosis and individualized management are crucial to prevent life-threatening complications and support appropriate growth and development. We report the case of a male preterm infant born at 33 weeks\u2019 gestation following a pregnancy complicated by severe polyhydramnios requiring multiple amnioreductions. At 2 weeks of age, he was admitted with severe dehydration, acute kidney injury (creatinine 205\u2005\u00b5mol\/L; eGFR 8\u2005mL\/min\/1.73m\n                    <jats:sup>2<\/jats:sup>\n                    ), marked polyuria (300\u2005mL\/kg\/day), and significant electrolyte abnormalities, including hyponatremia, hypokalemia, hypochloremia, and metabolic acidosis. During the first week of hospitalization, he developed necrotizing enterocolitis. Bartter syndrome was suspected based on the biochemical profile, perinatal history, and persistent electrolyte imbalance, and subsequently confirmed by identifying a pathogenic SLC12A1 variant (NM_001184832:c.1327G&amp;gt;A). Management required exceptionally high fluid volumes (280\u2013310\u2005mL\/kg\/day), intensive sodium and potassium supplementation, and gradual transition from parenteral to enteral nutrition. Following expert consultation, celecoxib was introduced (2.5\u2005mg\/kg twice daily), permitting stabilization of electrolyte homeostasis and discontinuation of parenteral nutrition by day 61 of life. Throughout hospitalization, complications included catheter-related inflammation, inferior vena cava thrombosis, anemia requiring transfusion, and stage II intraventricular hemorrhage. Serial renal ultrasonography demonstrated persistent nephrocalcinosis. During 30 months of follow-up, the patient exhibited normal neurodevelopmental progress but persistent challenges in growth, requiring endocrinology supervision. Laboratory parameters generally remained stable except for periodic hypercalciuria (Ca\/Crea &amp;gt;0.3). Episodes of intercurrent infections led to rapid electrolyte deterioration, necessitating intensified monitoring and supplementation. Celecoxib therapy remained essential, with unsuccessful attempts at dose reduction. Nephrocalcinosis persisted without deterioration in renal function. This case highlights that early diagnosis of type I Bartter syndrome enables timely targeted therapy but achieving stable fluid, electrolyte, and nutritional status remains challenging. Long-term management requires multidisciplinary care, vigilant monitoring during intercurrent illnesses, and individualized adjustments in pharmacologic and nutritional therapy. This report contributes valuable longitudinal insight into the complexities of managing neonatal-onset Bartter syndrome.\n                  <\/jats:p>","DOI":"10.3389\/fped.2026.1772606","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:43:22Z","timestamp":1773125002000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A newborn with type 1 Bartter syndrome: challenges in the treatment and development during 30 months follow-up\u2014a case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Justyna","family":"Czubili\u0144ska-\u0141ada","sequence":"first","affiliation":[{"name":"Department of Neonatal Intensive Care and Neonatal Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Szyma\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care and Neonatal Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sienko","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care and Neonatal Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Bade\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Behrendt","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care and Neonatal Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Szczepanska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0002-9343(62)90214-0","article-title":"Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome","volume":"33","author":"Bartter","year":"1962","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.kint.2020.10.035","article-title":"Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European rare kidney disease reference network working group for tubular disorders","volume":"99","author":"Konrad","year":"2021","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"908655","DOI":"10.3389\/fped.2022.908655","article-title":"Genetic heterogeneity in Bartter syndrome: clinical and practical importance","volume":"10","author":"Florea","year":"2022","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/IJNRD.S155397","article-title":"Bartter syndrome: causes, diagnosis, and treatment","volume":"11","author":"Cunha","year":"2018","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00467-019-04371-y","article-title":"Bartter and Gitelman syndromes: questions of class","volume":"35","author":"Besouw","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5049\/EBP.2022.20.2.49","article-title":"Bartter syndrome: perspectives of a pediatric nephrologist","volume":"20","author":"Choi","year":"2022","journal-title":"Electrolyte Blood Press"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000094001","article-title":"Bartter syndromes and other salt-losing tubulopathies","volume":"104","author":"Kleta","year":"2006","journal-title":"Nephron Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1523-1755.2002.00435.x","article-title":"Role of cyclooxygenase-2 in hyperprostaglandin E syndrome\/antenatal Bartter syndrome","volume":"62","author":"Reinalter","year":"2002","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12519-020-00370-4","article-title":"Bartter\u2019s syndrome: clinical findings, genetic causes and therapeutic approach","volume":"17","author":"Mrad","year":"2021","journal-title":"World J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/ckj\/sfx118","article-title":"Clinical and diagnostic features of Bartter and Gitelman syndromes","volume":"11","author":"Walsh","year":"2018","journal-title":"Clin Kidney J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21767\/2380-7245.100173","article-title":"Bartter syndrome, 15-year experience in the United Kingdom","volume":"4","author":"Kaur","year":"2018","journal-title":"J Rare Disord Diagn Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1111\/apa.12981","article-title":"Neonates with Bartter syndrome have enormous fluid and sodium requirements","volume":"104","author":"Azzi","year":"2015","journal-title":"Acta Paediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.32641\/rchped.v90i4.932","article-title":"Bartter syndrome: an infrequent tubulopathy of prenatal onset","volume":"90","author":"G\u00f3mez de la","year":"2019","journal-title":"Rev Chil Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3390\/nu13092960","article-title":"The dietary approach to the treatment of the rare genetic tubulopathies Gitelman\u2019s and Bartter\u2019s syndromes","volume":"13","author":"Francini","year":"2021","journal-title":"Nutrients"},{"key":"B15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s13312-020-1973-9","article-title":"Bartter syndrome masquerading as acute kidney injury in a neonate","volume":"57","author":"Jaladi","year":"2020","journal-title":"Indian Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1093\/ndt\/gfq119","article-title":"Long-term follow-up of patients with Bartter syndrome type I and II","volume":"25","author":"Puricelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/medicina59091638","article-title":"Bartter syndrome: a systematic review of case reports and case series","volume":"59","author":"Qasba","year":"2023","journal-title":"Medicina (B Aires)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e70749","DOI":"10.1002\/ccr3.70749","article-title":"Prenatal diagnosis of Bartter syndrome: lessons from a complex diagnostic procedure","volume":"13","author":"Samara","year":"2025","journal-title":"Clin Case Rep"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1772606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:43:23Z","timestamp":1773125003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1772606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":18,"alternative-id":["10.3389\/fped.2026.1772606"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1772606","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1772606"}}